YOLANDA ZARATE: Open Payments
NPI 1003036880 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,705 in 46 payments from 10 companies in 2025. Trend: 2023 $1,972 · 2024 $1,164 · 2025 $1,705
Food & beverage: $1,705
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $439 |
| ABBVIE INC. | 12 | $343 |
| Axsome Therapeutics, Inc. | 3 | $238 |
| Otsuka America Pharmaceutical, Inc. | 12 | $224 |
| E.R. Squibb & Sons, L.L.C. | 3 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $138 |
| Vanda Pharmaceuticals Inc. | 4 | $98 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| TMS NeuroHealth Centers Inc. | 1 | $10 |
Products named: AUSTEDO XR, VRAYLAR, Auvelity, REXULTI, COBENFY, CAPLYTA, HETLIOZ, FANAPT.
Industry payments across FL — which companies pay providers there.
